SCHEMBL9959290

SCHEMBL9959290

COc1cc2cc(C)[nH]c2cc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.52
EHMT2 Q96KQ7 1/20 0.48
KDM4E B2RXH2 3/20 0.42
MAPT P10636 3/20 0.42
ATM Q13315 1/20 0.42
CYP2A6 P11509 1/20 0.41
KEAP1 Q14145 1/20 0.41
ALDH1A1 P00352 5/20 0.38
PKM P14618 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
AMY1A P0DUB6 3/20 0.37
IRAK4 Q9NWZ3 1/20 0.37
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL266817 0.88 EHMT2 (0.62) AXLEHMT2KDM4EMAPTATM
SCHEMBL298208 0.81 AXL (0.49) AXLEHMT2KDM4EMAPTCYP2A6
SCHEMBL12505510 0.81 EHMT2 (0.55) AXLEHMT2KDM4EMAPTCYP2A6
SCHEMBL7043689 0.81 AXL (0.49) AXLEHMT2KDM4EMAPTCYP2A6
SCHEMBL11619589 0.81 AXL (0.49) AXLEHMT2CYP2A6KEAP1ALDH1A1
SCHEMBL10412474 0.78 CYP2A6 (0.50) AXLKDM4EMAPTATMCYP2A6
SCHEMBL16818978 0.77 AXL (0.49) AXLEHMT2CYP2A6KEAP1ALDH1A1
SCHEMBL3100380 0.75 SRD5A2 (0.58) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL12123168 0.75 CYP2A6 (0.56) AXLKDM4EMAPTCYP2A6KEAP1
SCHEMBL4568309 0.74 EHMT2 (0.43) AXLEHMT2KDM4EMAPTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9657012-B2 FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2017-05-23 US disclosed
EP-2655356-B1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS INC (US) 2016-08-03 EP disclosed
US-20150175599-A1 FAAH Inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2015-06-25 US disclosed
EP-2655356-A1 FAAH INHIBITORS Ironwood Pharmaceuticals, Inc. (US) 2013-10-30 EP disclosed
WO-2012088469-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175599-A1 FAAH Inhibitors FAAH, FAAH2, ASAH1 AXL 4046/4885EHMT2 3159/4885KDM4E 2260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.